U.S. Overactive Bladder Market
Frost & Sullivan
November 13, 2009 83 Pages - SKU: MC2504931
|
|
| This research service covers the U.S. overactive bladder market from 2005-2015. Included is a disease overview, product analysis, total market revenue forecasts, product revenue forecasts, patient forecasts and market share analysis. The market is segmented by product: Detrol, Detrol LA, Ditropan, Ditropan XL, Enablex, Oxytrol, Sanctura, Sanctura XR, VESIcare, and others. Major market challenges, drivers, and restraints and identified and discussed as well as pipeline by phase.
|
- 1. Executive Summary
- U.S. Overactive Bladder Market
- Introduction
- 2. Market Introduction Research
- Scope and Methodology
- Scope and Segmentation
- Research Methodology
- Market Overview
- Market Engineering Measurements
- Disease Overview
- Treatment Options
- Patient Forecasts
- Industry Challenges
- Market Drivers
- Market Restraints
- Product Analysis
- Product Analysis
- Product Comparisons
- Recently Approved Products
- Pipeline Analysis
- Phase III
- Phase II
- Phase I
- 3. Competitive Analysis
- Overview
- Competitive Structure
- Forecasts and Trends
- Total Market
- Revenue Forecasts by Product
- Market Share Analysis
- Company Market Share
- Product Market Share
- Drug Delivery Market Share
- 4. Appendix
- Decision Support Databases
- Population 65 Plus
- Female Population 65 Plus
- Male Population 65 Plus
- Total Life Expectancy at Birth
- Birth Rate
- List of Figures
- Chapter 2
- Overactive Bladder Market: Patient Forecasts by Gender (U.S.), 2005-2015
- Overactive Bladder Market: Male Patient Forecasts by Age (U.S.), 2005-2015
- Overactive Bladder Market: Female Patient Forecasts by Age (U.S.), 2005-2015
- Overactive Bladder Market: Treated Versus Total Patient Forecasts (U.S.), 2005-2015
- Overactive Bladder Market: Treated Patient Population Share by Product (U.S.), 2008
- Overactive Bladder Market: Impact of Top Four Industry Challenges (U.S.), 2009-2015
- Overactive Bladder Market: Market Drivers Ranked in Order of Impact (U.S.), 2009-2015
- Overactive Bladder Market: Market Restraints Ranked in Order of Impact (U.S.), 2009-2015
- Overactive Bladder Market: Product Analysis (U.S.), 2008
- Overactive Bladder Market: Reported Drug Efficacy as a Mean Reduction in Incontinence Episodes (U.S.), 2008
- Overactive Bladder Market: Percent of Patients Experiencing the Most Common Side Effects for Overactive Bladder Medications (U.S.), 2008
- Overactive Bladder Market: Recently Approved Product Analysis (U.S.), 2009
- Overactive Bladder Market: Phase III Pipeline Analysis (U.S.), 2009
- Overactive Bladder Market: Phase II Pipeline Analysis (U.S.), 2009
- Overactive Bladder Market: Phase I Pipeline Analysis (U.S.), 2009
- Chapter 3
- Overactive Bladder Market: Competitive Structure (U.S.), 2008
- Overactive Bladder Market: Revenue Forecasts (U.S.), 2005-2015
- Overactive Bladder Market: Revenue Forecasts for Branded Products (U.S.), 2005-2015
- Overactive Bladder Market: Revenue Forecasts for Generic Products (U.S.), 2005-2015
- Overactive Bladder Market: Company Market Share by Revenues (U.S.), 2008
- Overactive Bladder Market: Company Market Share by Revenues (U.S.), 2015
- Overactive Bladder Market: Product Market Share by Revenues (U.S.), 2008
- Overactive Bladder Market: Product Market Share by Revenues (U.S.), 2015
- Overactive Bladder Market: Revenues by Delivery Type (U.S.), 2008/2015
Share this report
Other tasks Related Markets Urology Reports Free Alert Me service Receive bi-weekly email alerts on new market research Sign Up Today!
|
